c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of

Yi-Feng Huang1, Jing-Jer Lin, Chao-Hsiung Lin

  • 1Department of Life Sciences, Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan.

Insights

JNK1 activation by bone morphogenetic protein 2 (BMP2) inhibits osteoblastic differentiation by phosphorylating Runx2 at Ser104. Inhibiting JNK1 enhances osteoblast differentiation, offering new strategies for bone formation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Runx2 is essential for osteoblastic differentiation, often upregulated by BMP2.
  • MAPK pathways, including ERK and p38, are activated by BMP2 to enhance Runx2 activity.
  • The role of JNK in osteoblastic differentiation remains unclear.

Purpose of the Study:

  • To investigate the role of JNK1 in BMP2-induced osteoblastic differentiation.
  • To elucidate the molecular mechanism by which JNK1 affects osteoblastic differentiation.
  • To identify potential therapeutic targets for enhancing bone formation.

Main Methods:

  • Utilized C2C12 and MC3T3-E1 cell lines.
  • Investigated JNK1 activation by BMP2.
  • Employed JNK inhibitors, knockdown, and dominant-negative/constitutively active JNK1 constructs.
  • Analyzed Runx2 phosphorylation at Ser104.
  • Assessed osteoblastic differentiation markers (ALP expression, mineralization).

Main Results:

  • BMP2 activates JNK1 in osteoblastic cells.
  • JNK1 loss-of-function enhances BMP2-induced osteoblastic differentiation.
  • JNK1 gain-of-function reduces BMP2-induced osteoblastic differentiation.
  • JNK1 phosphorylates Runx2 at Ser104, inhibiting osteoblastic differentiation.
  • Mutant Runx2 (Ser104Ala) mimics the effect of JNK inhibition.

Conclusions:

  • JNK1 negatively regulates BMP2-induced osteoblastic differentiation via Runx2 phosphorylation at Ser104.
  • Understanding this mechanism provides insights for developing strategies to promote osteoblastic differentiation and bone formation.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...